Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma

SIMPLE SUMMARY: Glioblastomas are high-grade brain tumours and are the most common form of malignancy arising in the brain. Patient survival has improved little over the last 40 years, highlighting an urgent unmet need for more effective treatments for these tumours. Current standard-of-care treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Carmell, Natasha, Rominiyi, Ola, Myers, Katie N., McGarrity-Cottrell, Connor, Vanderlinden, Aurelie, Lad, Nikita, Perroux-David, Eva, El-Khamisy, Sherif F., Fernando, Malee, Finegan, Katherine G., Brown, Stephen, Collis, Spencer J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956595/
https://www.ncbi.nlm.nih.gov/pubmed/33668183
http://dx.doi.org/10.3390/cancers13050944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956595/
https://www.ncbi.nlm.nih.gov/pubmed/33668183
http://dx.doi.org/10.3390/cancers13050944

Ejemplares similares